Remibrutinib, an oral Bruton tyrosine kinase inhibitor (BTKi), was approved for the treatment of chronic spontaneous ...
The investigational antimyostatin drug improves restoration of lean mass after semaglutide discontinuation, with greater ...
More than two thirds of clinicians who treat children say they are following the AAP’s guidelines. Half of respondents said ...
Statin use is associated with a 15% lower risk of developing open-angle glaucoma at 5 years and with lower rates of laser and ...
Seven occupational solvents have been linked to Parkinson’s disease, with greater risk among people exposed to more than one, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results